Abstract

Society needs alternatives to painful, expensive, and cumbersome injections for diseases like diabetes. Franko et al. developed cells that sense melatonin to deliver glucagon-like peptide-1 (GLP-1) therapy during sleep. This circadian-synchronized approach restored normal blood sugar in diabetic mice, advancing the field of smart cells for patient-centered circadian medicine.

Original languageEnglish
Article number101484
JournalCell Systems
Volume16
Issue number12
DOIs
StatePublished - Dec 17 2025

Fingerprint

Dive into the research topics of 'Set it and forget it: Engineered cells for drug delivery'. Together they form a unique fingerprint.

Cite this